[Pharmacokinetics of three peroral dosage forms of new dipeptide anxiolytic drug GB-115]. 2014

E V Ivannikova, and S S Boĭko, and V P Zherdev, and S Iu Raskin, and E V Blynskaia, and K G Turchinskaia, and A A Illarionov

Comparative analysis of the pharmacokinetics and bioequivalence of a new dipeptide anxiolytic compound GB-115 in three drug forms for peroral administration, developed in the experimental technology department of the Institute of pharmacology RAMS, was carried out. Three drug forms of GB-115 and a micronized substance of this compound were different in composition and technology of production. As a result of the investigations of GB-115 pharmacokinetics, drug form No. 2 (with a relative bioequivalence of 192%) showed advantages in comparison to the micronized parent substance and two other drug forms (bioequivalence, 53 and 117%) and can be recommended for further pharmacological studies.

UI MeSH Term Description Entries
D008297 Male Males
D004151 Dipeptides Peptides composed of two amino acid units. Dipeptide
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D014151 Anti-Anxiety Agents Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. Anti-Anxiety Agent,Anti-Anxiety Drug,Anxiolytic,Anxiolytic Agent,Anxiolytic Agents,Tranquilizing Agents, Minor,Anti-Anxiety Drugs,Anti-Anxiety Effect,Anti-Anxiety Effects,Antianxiety Effect,Antianxiety Effects,Anxiolytic Effect,Anxiolytic Effects,Anxiolytics,Tranquillizing Agents, Minor,Agent, Anti-Anxiety,Agent, Anxiolytic,Agents, Anti-Anxiety,Agents, Anxiolytic,Agents, Minor Tranquilizing,Agents, Minor Tranquillizing,Anti Anxiety Agent,Anti Anxiety Agents,Anti Anxiety Drug,Anti Anxiety Drugs,Anti Anxiety Effect,Anti Anxiety Effects,Drug, Anti-Anxiety,Drugs, Anti-Anxiety,Effect, Anti-Anxiety,Effect, Antianxiety,Effect, Anxiolytic,Effects, Anti-Anxiety,Effects, Antianxiety,Effects, Anxiolytic,Minor Tranquilizing Agents,Minor Tranquillizing Agents
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

E V Ivannikova, and S S Boĭko, and V P Zherdev, and S Iu Raskin, and E V Blynskaia, and K G Turchinskaia, and A A Illarionov
January 2015, Eksperimental'naia i klinicheskaia farmakologiia,
E V Ivannikova, and S S Boĭko, and V P Zherdev, and S Iu Raskin, and E V Blynskaia, and K G Turchinskaia, and A A Illarionov
June 2013, Bulletin of experimental biology and medicine,
E V Ivannikova, and S S Boĭko, and V P Zherdev, and S Iu Raskin, and E V Blynskaia, and K G Turchinskaia, and A A Illarionov
October 2012, Bulletin of experimental biology and medicine,
E V Ivannikova, and S S Boĭko, and V P Zherdev, and S Iu Raskin, and E V Blynskaia, and K G Turchinskaia, and A A Illarionov
May 2008, Bulletin of experimental biology and medicine,
E V Ivannikova, and S S Boĭko, and V P Zherdev, and S Iu Raskin, and E V Blynskaia, and K G Turchinskaia, and A A Illarionov
September 2007, Bulletin of experimental biology and medicine,
E V Ivannikova, and S S Boĭko, and V P Zherdev, and S Iu Raskin, and E V Blynskaia, and K G Turchinskaia, and A A Illarionov
June 2010, Eksperimental'naia i klinicheskaia farmakologiia,
E V Ivannikova, and S S Boĭko, and V P Zherdev, and S Iu Raskin, and E V Blynskaia, and K G Turchinskaia, and A A Illarionov
January 2011, Vestnik Rossiiskoi akademii meditsinskikh nauk,
E V Ivannikova, and S S Boĭko, and V P Zherdev, and S Iu Raskin, and E V Blynskaia, and K G Turchinskaia, and A A Illarionov
January 2011, Eksperimental'naia i klinicheskaia farmakologiia,
E V Ivannikova, and S S Boĭko, and V P Zherdev, and S Iu Raskin, and E V Blynskaia, and K G Turchinskaia, and A A Illarionov
March 1973, Bollettino chimico farmaceutico,
E V Ivannikova, and S S Boĭko, and V P Zherdev, and S Iu Raskin, and E V Blynskaia, and K G Turchinskaia, and A A Illarionov
June 1980, Vardfacket,
Copied contents to your clipboard!